Evidence map›Paper›PMID 38717195›Full record

ArticleVirulence2024

Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients.

Pin-Xian Du, Shen-Shin Chang, Tzong-Shiann Ho, Hsi-Chang Shih, Pei-Shan Tsai, Guan-Da Syu

Abstract read
In one paragraph

Article in Virulence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pin-Xian DuDepartment of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
Shen-Shin ChangDivision of Transplantation, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Tzong-Shiann HoCenter of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.
Hsi-Chang ShihDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, USA.
Pei-Shan TsaiDepartment of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
Guan-Da SyuDepartment of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0003-4661-414X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

2019-nCoV Vaccine mRNA-1273Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesImmunity, HumoralKidney TransplantationSARS-CoV-2Spike Glycoprotein, CoronavirusAdultAgedFemaleHumansImmunosuppressive AgentsMaleMiddle Aged2019-nCoV Vaccine mRNA-1273Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesImmunosuppressive AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2angiotensin-converting enzyme 2COVID-19Kidney transplant recipientsSARS-CoV-2vaccinevariants of concern

Identifiers

PMID38717195
PMCPMC11085947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.